Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
原文: https://www.cnbc.com/2026/09/21/novo-nordisk-stock-sales-target-obesity-drugs.html
Last Update:
21 9 月, 2026
